11-125627771-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001114122.3(CHEK1):c.230G>T(p.Gly77Val) variant causes a missense change. The variant allele was found at a frequency of 0.000187 in 1,612,834 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001114122.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00127 AC: 194AN: 152178Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.000386 AC: 97AN: 251008Hom.: 0 AF XY: 0.000339 AC XY: 46AN XY: 135722
GnomAD4 exome AF: 0.0000739 AC: 108AN: 1460656Hom.: 1 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 726662
GnomAD4 genome AF: 0.00127 AC: 194AN: 152178Hom.: 4 Cov.: 32 AF XY: 0.00195 AC XY: 145AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.230G>T (p.G77V) alteration is located in exon 3 (coding exon 2) of the CHEK1 gene. This alteration results from a G to T substitution at nucleotide position 230, causing the glycine (G) at amino acid position 77 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
CHEK1-related disorder Uncertain:1
The CHEK1 c.230G>T variant is predicted to result in the amino acid substitution p.Gly77Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.28% of alleles in individuals of Latino descent in gnomAD and is not reported in ClinVar. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at